Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
Background: There is a large amount of evidence that anti-angiogenic drugs are effective safe. However, few studies have evaluated the specific effects of anti-angiogenic drugs on myocardial enzyme injury biomarkers: aspartate aminotransferase (AST), lactic dehydrogenase (LDH), creatine kinase (CK)...
Guardado en:
Autores principales: | Qi Zheng, Hanzhou Wang, Wei Hou, Ying Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e760e4e626e14368a55662b5ce4f0672 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pure Micropapillary Rectal Carcinoma with CK7 and CK20 Coexpression and Loss of CDX2 Reactivity
por: Lino-Silva,Leonardo Saúl
Publicado: (2012) -
CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation
por: Lea Elsholz, et al.
Publicado: (2021) -
Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy
por: Habte ML, et al.
Publicado: (2020) -
Protein kinase CK2 in TGFβ-induced lens epithelial-mesenchymal transition
por: Alexander Oscar, et al.
Publicado: (2021) -
The CK1 gene family: expression patterning in zebrafish development
por: ALBORNOZ,AMELINA, et al.
Publicado: (2007)